Published • loading... • Updated
Investigation of baicalin, baicalein and low-dose sulfasalazine for orocecal transit time determination in saliva and plasma
Summary by Pharma Excipients
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Investigation of baicalin, baicalein and low-dose sulfasalazine for orocecal transit time determination in saliva and plasma
Abstract The application of high-dose sulfasalazine (≥ 500 mg) followed by plasma or salivary sampling represents an established method for orocecal transit time determination. In the present study, we aimed to establish an alternative procedure. For this, we investigated. whether the onset of baicalin or its aglycon baicalein in plasma or saliva after oral application correlated with the onset of sulfapyridine in plasma and. whether the onse…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
